The Study
Differential effects of atorvastatin on calcification in stromal and vascular cells within monolayer and 3D plaque cap models.
This study looked at how a medicine affects tiny human cells in a petri dish, not in real people. It shows what happened to those cells, but we can't say if it does the same thing in your body or if it helps or hurts your heart.
Analysis score
Maximum 58 for a case-control study.
Where the score came from
Statins help prevent heart attacks, but this study found they can make certain cells in artery plaques deposit more calcium — like tiny rocks — while stopping other cells from doing it.
Where does this study sit?
Reviews of RCTs (Meta-analyses)
Max 100Randomized Trials
Max 90Reviews of Cohort Studies
Max 85Cohort Studies
Max 72Reviews of Case-Control Studies
Max 63Case-Control Studies
Max 58Cross-Sectional & Case Series
Max 50Expert Opinion
Max 531 / 100
Quality score
Researchers compare people who have a condition (cases) with similar people who do not (controls), looking back in time for differences in exposure. Useful but more prone to bias.
Key takeaways
Summary
Based on the study abstract and findings.
- 1This may explain why statins lower heart attack risk even as calcium scores rise — they stabilize plaques by changing how different cells behave, not just by reducing cholesterol.
- 2In one type of cell (mSMCs), 1–10 μM atorvastatin caused more calcification in both flat and 3D models.
- 3In another (MSCs), it reduced calcification.
- 4In vein cells (HVSCs), it worked in flat dishes but not in 3D.
Score breakdown, methodology, conflicts of interest, evidence analysis & raw study data
Publication
Journal
Biochemical and biophysical research communications
Year
2026
Authors
I. Jansen, J. Witte-Bouma, J. E. Roeters van Lennep, M. T. Mulder, K. van der Heiden, E. Farrell
Related Content
Claims (6)
Statins increase calcium buildup in arteries while lowering the risk of heart attacks and strokes by making atherosclerotic plaques more stable.
Atorvastatin reduces calcium buildup in human vein cells grown in flat lab dishes, but has no effect on calcium buildup in lab-grown 3D plaque structures, showing that the physical environment changes how cells respond to the drug.
Atorvastatin affects calcium buildup in different types of human vascular cells differently, depending on the cell's original source and maturity level.
The concentration of atorvastatin tested in the lab matches the levels found in the blood of patients taking the drug at standard doses, so the effects seen in the lab likely occur in patients.
In laboratory cultures, atorvastatin reduces mineral buildup in human mesenchymal stromal cells but increases mineral buildup in human smooth muscle-like cells derived from the same cell type.
Atorvastatin at concentrations of 1–10 μM causes calcification in human smooth muscle-like cells grown in a 3D tissue-engineered model of arterial plaque, consistent with its effect in 2D cell cultures.
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.